Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review
Abstract Background Children and adolescents are at increased risk of progressing from latent to active tuberculosis (TB). The 3-month, once-weekly isoniazid and rifapentine (3HP) regimen offers a shorter tuberculosis preventive treatment (TPT) option. However, evidence regarding its completion rate...
Saved in:
| Main Authors: | Sipang Pangprasertkul, Nida Buawangpong, Kanokporn Pinyopornpanish, Wichuda Jiraporncharoen, Chaisiri Angkurawaranon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-10832-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of a novel short course rifapentine and isoniazid regimen for the preventive treatment of tuberculosis in Chinese silicosis patients: a pilot study (SCRIPT-TB)
by: Qiao-Ling Ruan, et al.
Published: (2025-12-01) -
THE ANTI-TUBERCULOSIS ANTIBIOTIC OF RIFAPENTINE: PERSPECTIVES OF CLINICAL USE
by: A. G. Samoylova, et al.
Published: (2019-01-01) -
Tuberculosis preventive treatment in newborns
by: Tony TannousTahan, et al.
Published: (2025-01-01) -
Experience of using rifapentine in continuation phase of treatment of adult tuberculosis cases
by: T. I. Morozova, et al.
Published: (2019-07-01) -
Completion of tuberculosis preventive treatment with 300 mg vs. 100 mg isoniazid tablets: a pragmatic randomized clinical trial
by: João Paulo Cola, et al.
Published: (2025-03-01)